Royal Bank of Canada’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $143K | Buy |
65,197
+54,122
| +489% | +$119K | ﹤0.01% | 5046 |
|
|
2025
Q1 | $15K | Buy |
11,075
+2,268
| +26% | +$3.07K | ﹤0.01% | 5623 |
|
|
2024
Q4 | $12K | Sell |
8,807
-40,722
| -82% | -$55.5K | ﹤0.01% | 5791 |
|
|
2024
Q3 | $57K | Sell |
49,529
-195
| -0.4% | -$224 | ﹤0.01% | 5174 |
|
|
2024
Q2 | $65K | Sell |
49,724
-2,000
| -4% | -$2.61K | ﹤0.01% | 5132 |
|
|
2024
Q1 | $102K | Buy |
51,724
+1,571
| +3% | +$3.1K | ﹤0.01% | 4732 |
|
|
2023
Q4 | $72K | Sell |
50,153
-3,265
| -6% | -$4.69K | ﹤0.01% | 5273 |
|
|
2023
Q3 | $70K | Sell |
53,418
-15
| -0% | -$20 | ﹤0.01% | 5104 |
|
|
2023
Q2 | $92K | Buy |
53,433
+1,363
| +3% | +$2.35K | ﹤0.01% | 4962 |
|
|
2023
Q1 | $94K | Buy |
52,070
+236
| +0.5% | +$426 | ﹤0.01% | 4849 |
|
|
2022
Q4 | $138K | Buy |
51,834
+1,462
| +3% | +$3.89K | ﹤0.01% | 4744 |
|
|
2022
Q3 | $167K | Sell |
50,372
-7,851
| -13% | -$26K | ﹤0.01% | 4432 |
|
|
2022
Q2 | $211K | Buy |
58,223
+6,938
| +14% | +$25.1K | ﹤0.01% | 4325 |
|
|
2022
Q1 | $261K | Buy |
51,285
+48,235
| +1,581% | +$245K | ﹤0.01% | 4384 |
|
|
2021
Q4 | $23K | Sell |
3,050
-1,095
| -26% | -$8.26K | ﹤0.01% | 6200 |
|
|
2021
Q3 | $61K | Buy |
4,145
+3,700
| +831% | +$54.5K | ﹤0.01% | 5524 |
|
|
2021
Q2 | $8K | Buy |
+445
| New | +$8K | ﹤0.01% | 6431 |
|